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Our Institute’s nuclear, biological, and chemical defense research team continuously investigates and 
develops preparations for skin decontamination against nerve agents. In this in vivo study, we evaluated skin 
decontamination effi cacy against sarin by a synthetic preparation called Mineral Cationic Carrier (MCC®) 
with known ion exchange, absorption effi cacy and bioactive potential. Mice were treated with increasing 
doses of sarin applied on their skin, and MCC® was administered immediately after contamination. The 
results showed that decontamination with MCC® could achieve therapeutic effi cacy corresponding to 3 x 
LD
50
 of percutaneous sarin and call for further research.
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Organophosphate (OP) nerve agents (G-agents 
and VX) are related to the OP pesticides, but have a 
much higher mammalian acute toxicity, particularly 
through skin and inhalation route (1-4).
Warfare nerve agent sarin is a codename suggested 
by Schrader as a derivation of Schrader, Ambros, 
Rüdriger and Van der Linde, who synthesised the 
compound. Its acute effects are primarily due to 
unrestricted cholinergic activity at both muscarinic 
and nicotinic receptors (1, 3-5). The threat of skin 
contamination by nerve agents calls for effective 
primary decontamination preparation for naked skin (6). 
Developing effective treatment and decontamination 
systems has proven to be a demanding task. Not only 
do the varying chemical properties of nerve agents 
impede the development of a single, “universal” 
decontaminant, but the extreme toxicities of these 
agents necessitate a matching counter-efficiency. 
Searching for a new decontaminant, we focused on 
the three main forms: 1. decontamination solutions 
and emulsions, 2. decontamination ointments, gels 
and pastes; and 3. decontamination adsorption and 
chemisorption powders (7).
However, many of the preparations for skin 
decontamination against nerve agents are toxic. 
Accordingly, army-issue personal decontamination 
kits include substances and preparations which are 
non-toxic, ecologically acceptable and safe (2, 8, 9). 
Previous research indicated that a synthetic powder 
Mineral Cationic Carrier (MCC®), otherwise used 
as a dietary supplement, possesses ion exchange, 
absorption, and bioactive potential to counteract skin 
contamination by nerve agents (10-12).
Preclinical toxicology testing performed according 
to the standards and regulations of the Organization 
for Economic Cooperation and Development (OECD) 
did not indicate acute, sub-chronic, or chronic toxicity 
of the preparation (11), and it proved effi cacious 
against skin contamination with warfare nerve agent 
sulphur mustard (13). In this study, we investigated 





Sarin was used as a contaminant in accordance 
with the Chemical Weapons Convention (14). The 







F) was obtained from the Laboratory for 
NBC Protection and Biomonitoring (Zagreb, Croatia). 
Solution of sarin (c=100 mg L-1) was prepared in 
isopropanole (Sigma, USA).
MCC® (patent HR2002/000034) is a calcium/
sodium (30:70) powder preparation synthesised 
at Ruđer Bošković Institute (Zagreb, Croatia) and 
manufactured by KODONA (Zagreb, Croatia). Details 
about its form and synthesis are given elsewhere (11, 
13).
In vivo experiments
Mice (NOD strain) were purchased from Ruđer 
Bošković Institute. The experiment included adult 
animals of both sexes at approximately 12 to 30 weeks 
of age and 28 to 32 g of weight. Before the experiment, 
the animals were kept under conventional conditions 
and were receiving food and water ad libitum.
The study was carried out according to the NIH 
Guide for the Care and Use of Laboratory Animals. 
Experiments received necessary approvals from 
the Local Ethics Committee. The day before the 
experiment, the mice were marked, weighed, shaved 
using electric shaver, and divided in groups of four. 
Immediately before receiving sarin, they were sedated 
with 35 mg kg-1 b. w. pentobarbital sodium solution 
(Nembutal®, Abbot Lab., Chicago, USA). Sarin was 
administered on the shaved back skin of the animals 
in increasing volumes of (0 to 1.4) mL using a 
pipetman by Eppendorf. About 2 g of MCC® powder 
was sprinkled over the same site and rubbed in with a 
spoon one minute after contamination with sarin. The 
effi cacy of the preparation was tested on four mice per 
dose and experiments were repeated twice.
To determine mortality rate in following 24 hours, 
animals that survived the experiment were returned 
to cages and kept in conventional conditions. After 
24 hours the surviving animals were sedated and 
sacrifi ced.
Median lethal sarin dose (LD
50
) and 95 % limit 
of reliability (L
R
) were calculated from Weil’s tables 
(15) using the following equations:
log LD
50
 = log D
A
 + log G
f
 (1+f)
log 95 % L
R
 = log LD
50
 ± 2d x σ
The therapeutic decontamination effect (TDE) of 
MCC® was calculated using the following equation: 
TDE =LD
50 





MCC® is a synthetic zeolite with a three-
dimensional net structure and known ion exchange, 
absorption effi ciency, and bioactive potential (9-12, 
19-22). Our earlier study on CBA has shown that 
it is also an effi cacious skin decontaminant against 
high doses of sulphur mustard (13). This study was 
performed on a similar in vivo model (NOD mice) 
to evaluate the effi cacy of MCC® against chemical 
warfare agent sarin. We applied the same array of 
methods as proposed in earlier research (16-19).
The median lethal dose of percutaneous sarin for 
NOD mice is 1221.80 µg kg-1. According to literature 
data (17) it is within the 95 % limit of reliability (95 % 
L
R
) (Table 1). Animals which received the lethal or 
a higher dose of sarin but not MCC® died within 
20 minutes. They showed tremors and convulsions 
immediately after sarin was applied onto the skin.
Table 2 shows the volumes of sarin solution 
applied on the mouse skin and detailed data on animals 
that survived 24 h after the experiment. Without 
decontamination, sarin caused 50 % (2/4) and 100 % 
(4/4) mortality in the doses of 1452.86 µg kg-1 and 
1830.60 µg kg-1, respectively (Figure 1). To evaluate 
the effi cacy of MCC® we used the same two doses 
of sarin and four higher doses on a second group of 
NOD mice. Figure 1 shows that MCC® can increase 
the survival of contaminated mice even at these higher 
doses. Mice decontaminated with MCC® tolerated 
the dose of 3662.68 µg kg-1, which is three times the 
sarin’s percutaneous LD
50
 (Table 2). The recovered 
animals had no skin changes, which was confi rmed 
24 hours after exposure and treatment.
Together with our earlier findings (13), these 
results suggest that MCC® is a promising antidote 
against sulphur mustard and sarin because of a great 
absorption potential (5, 24-27) owed to its three-
dimensional net structure and micro-size inorganic 
particles.
CONCLUSION
Although sulphur mustard and sarin have a 
different molecular structure, MCC® was able to 
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Table 1 Skin decontamination against nerve agent sarin determined in vivo.
Group of mice
Skin poisoning with sarin
LD
50
 / µg kg-1 95 % L
R
 / µg kg-1 TDE
Without decontamination 1221.80 956.31 to 1560.99 /
With decontamination 3662.68 3204.79 to 4186.01 3
TDE - therapeutic decontamination effect
95 % L
R
 - limit of reliability
Table 2  Survival of mice (NOD strain) contaminated with LD
50
 sarin solution in isopropanole (c=100 mg L-1) with and without 




 sarin solution 















D - number of dead mice, C - number of contaminated mice
Figure 1  Mortality of mice (NOD strain) contaminated with LD
50
 sarin solution in isopropanole (c=100 mg L-1) with and 
without skin decontamination with MCC®
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absorb them, inactivate, and prevent severe poisoning 
in mice receiving doses as high as 8.4 and three times 
the respective percutaneous LD
50
.
Our fi nding speaks in favour of current research 
of inorganic microparticles like MCC® as reactive 
sorbents for the decontamination of chemical warfare 
agents (20, 28, 29). However, further in vivo studies 
should elucidate whether the preparation is safe for 
extensive use in military personnel and whether it is 
environmentally friendly. 
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Sažetak
KOŽNA DEKONTAMINACIJA ŽIVČANOGA BOJNOG OTROVA SARINA S APSORPCIJSKIM 
PRIPRAVKOM U UVJETIMA IN VIVO
Istraživački tim NBKO (nuklearno-biološko-kemijske obrane) radi na pronalasku i razvoju pripravka za 
dekontaminaciju kože od živčanih bojnih otrova. Cilj ovog istraživanja bio je ispitati dekontaminacijska 
svojstva (adsorpcijska i/ili kemisorpcijska) pripravka MCC® rabeći živčani bojni otrov sarin kao 
kožni kontaminant u uvjetima in vivo. MCC® je sintetski pripravak koji je biokemijski aktivan i ima 
ionskoizmjenjivačka i adsorpcijska svojstva. Istraživanje u uvjetima in vivo napravljeno je na miševima 
aplikacijom rastućih doza sarina na kožu životinje. Pripravak MCC® uporabljen je kao kožni dekontaminant 
neposredno nakon kožne kontaminacije sarinom. Istraživanja su pokazala da pripravak MCC® posjeduje 
adsorpcijska svojstva, ujedno važna za dekontaminaciju živčanih bojnih otrova. Eksperimenti u uvjetima 
in vivo na miševima (NOD-soj) pokazali su da se dekontaminacijom pripravkom MCC® može postići 
terapijski učinak od 3 LD
50
 (perkutano, sarin).
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